Phase I dose escalation safety and feasibility study of autologous WT1-sensitized T cells for the treatment of patients with recurrent ovarian cancer
=====================================================================================================================================================

* Chrisann Kyi
* Ekaterina Doubrovina
* Qin Zhou
* Sara Kravetz
* Alexia Iasonos
* Carol Aghajanian
* Paul Sabbatini
* David Spriggs
* Richard J O'Reilly
* Roisin E O’Cearbhaill